Vifor Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Vifor Pharma has a total shareholder equity of CHF4.0B and total debt of CHF540.2M, which brings its debt-to-equity ratio to 13.6%. Its total assets and total liabilities are CHF5.1B and CHF1.1B respectively. Vifor Pharma's EBIT is CHF377.5M making its interest coverage ratio -377.5. It has cash and short-term investments of CHF993.6M.
Key information
13.6%
Debt to equity ratio
CHF540.20m
Debt
| Interest coverage ratio | -377.5x |
| Cash | CHF993.60m |
| Equity | CHF3.97b |
| Total liabilities | CHF1.13b |
| Total assets | CHF5.10b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VIFNZ's short term assets (CHF1.9B) exceed its short term liabilities (CHF981.3M).
Long Term Liabilities: VIFNZ's short term assets (CHF1.9B) exceed its long term liabilities (CHF149.2M).
Debt to Equity History and Analysis
Debt Level: VIFNZ has more cash than its total debt.
Reducing Debt: VIFNZ's debt to equity ratio has reduced from 87.6% to 13.6% over the past 5 years.
Debt Coverage: VIFNZ's debt is well covered by operating cash flow (97.6%).
Interest Coverage: VIFNZ earns more interest than it pays, so coverage of interest payments is not a concern.